Tenofovir DF (TDF) showed superior antiviral efficacy to adefovir dipivoxil in a randomized, double-blind, study for the treatment of HBeAg-positive chronic hepatitis B (CHB)
Titel:
Tenofovir DF (TDF) showed superior antiviral efficacy to adefovir dipivoxil in a randomized, double-blind, study for the treatment of HBeAg-positive chronic hepatitis B (CHB)
Auteur:
Andreone, P. Heathcote, J. Rizzetto, M. Gane, E. DeMan, R. Lee, S. Flisiak, R. Sorbel, J. Anderson, J. Mondou, E. Rousseau, F.